JOAN NARDEO: Open Payments
NPI 1821788209 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 23 payments from 15 companies in 2025. Trend: 2023 $604 · 2024 $542 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $212 |
| Eisai Inc. | 2 | $47 |
| PFIZER INC. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Radius Health, Inc. | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Agios Pharmaceuticals, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Novo Nordisk Inc | 1 | $21 |
| Exact Sciences Corporation | 1 | $21 |
Products named: BREZTRI, AIRSUPRA, FARXIGA, Leqembi, LEQVIO, CAPVAXIVE, PYRUKYND, XIFAXAN.
Industry payments across FL — which companies pay providers there.
